Chronic disease is transforming health, medical costs and the delivery of care. Diseases such as diabetes, heart failure, emphysema, and cancer are chronic. Once developed, they usually last a lifetime, are challenging to manage and are expensive to treat.
Approximately 15 percent of those with a COVID-19 infection will develop long COVID. Long COVID is prevalent and more common among females and older individuals.
Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level.
